Wednesday, August 24, 2022, 2:00 PM ET

Digital innovation is transforming the world of drug development and better equipping pharmaceutical companies than ever before to deliver the right treatments to the right patients, at the right time. Nonetheless, as these technologies evolve, there is still much to learn.


In this forward-thinking panel event, Fast Company and Bristol Myers Squibb’s thought leaders and top executives are convening to share their insights on the extraordinary opportunities that lie ahead.


  • How to leverage the existing electronic medical record environment and digitally enabled clinical trials to accelerate clinical development and change the status quo

  • How to utilize patient-centric approaches to collect data and communicate with investigator sites to mitigate patient burden

  • How to shape further innovation to allow for solutions that serve more diverse and inclusive patient populations